c o r r e s p o n d e n c e public data archives for genomic structural variation
To the Editor:
When the road map for sequencing the human genome was laid out, the study of genetic variation was deemed a critical component 1 , with the mapping of SNPs initially being a priority. The availability of a high quality human reference assembly 2 facilitated the discovery and characterization of structural variation of DNA, with copy number variation being its most abundant form [3] [4] [5] . As other multicellular organisms were sequenced, structural variation was observed to be a ubiquitous feature of genomes 6, 7 . The dbSNP 8 database was created early in 1998 to manage SNP and small-scale variation data, but it was not designed for larger and more complex structural variation data. The explosion of data from diverse structural variation studies now necessitates the development of a public data archive. Here, we describe two official companion databases, dbVar and DGVa, serving this community role.
Public data archives play a major role in supporting the scientific community. They provide stable and traceable identifiers and allow for a single point of access for data collections, facilitating data download and meta-analysis across studies. The Database of Genomic Variants (DGV) was developed in 2004 to support public access to human genomic structural variation data for use in biomedical studies. DGV has served a very important role in collecting and analyzing structural variation studies, but it is not designed to provide a comprehensive and perpetual archive and has discontinued accepting direct submissions. Instead, DGV will work in partnership with the new archives and use them as the primary source of structural variation information, ensuring that the data in DGV is synchronized with accessioned structural variations in dbVar and DGVa. The main role of DGV going forward will be to curate and visualize selected studies to facilitate interpretation of structural variation data, including implementing the highest-level quality standards required by the clinical and diagnostic communities. The complex nature of structural variation often makes it less amenable than other genomic data (for example, SNPs) to single-step electronic mapping to reference genomes, necessitating significant manual curation efforts, a critical contribution which DGV will continue to perform (Fig. 1) .
Efforts are ongoing to populate dbVar and DGVa with the historical studies from DGV, and 29 of these studies, including efforts to provide a comprehensive description of the structural variation landscape, such as study estd20 (Conrad et al.) 9 , have been loaded as of August 2010, with the remaining studies to follow shortly. As part of this transition, the scope of data represented will be expanded. Studies examining the association of structural variations with phenotypes and the structural variation characterization of cancer genomes will be included. Studies with participants that have not consented to the release of their genetic information in an open, public database can submit sample-level data to the European Genome-phenome Archive (EGA) or the Database of Genotype and Phenotype (dbGaP). For these studies, sample-level data will be held in the controlled access archives, and only summary-level data will be released to the DGVa and dbVar archives. One such study, nstd11 (Walter et al.) 10 , has already been submitted through this pathway. Additionally, studies from diverse species will be included in an effort to support comparative analysis of structural variation.
dbVar and DGVa use a common data model (Supplementary Fig. 1) , share identifiers and exchange data on a regular basis; the two databases expect to be synchronized with respect to data content by the end of 2010. Identifiers are assigned at three levels: the study level, the variants region level and the supporting variant level. Identifiers assigned at EBI will be prefixed with an 'e' and those assigned at NCBI will be prefixed with an 'n' . At this time, DGV will also be updated to synchronize with the data in the new archives. The majority of data loaded to date have been formatted by internal staff in consultation with the authors, although the public archives are moving toward direct submissions by authors, and a limited number of studies End users Figure 1 The workflow for data submission and curation. Data from published works or community resources will be submitted to either dbVar or DGVa. The groups use a common tracking system for data loading and currently coordinate monthly releases. Once data has been synchronized, DGV will collect data from DGVa in order to curate selected human datasets. End users will be able to obtain data from all three sources.
access and for providing value-added tools. DGVa data will be integrated with other EBI resources, including the comprehensive EBI search and the Ensembl genome browser 15 . DGVa has been designed to facilitate the curatorial work of DGV. In addition to coordinating with public browsers, dbVar has an independent site where users can use the Entrez 8 query system to search for individual variants or studies. This site is integrated with other NCBI resources, and links to other databases are readily available. dbVar is currently working to map all data onto common coordinate systems and provide some minimal curation by cross referencing this data with information from the Genome Reference Consortium (GRC) in order to identify called variants that are likely artifacts due to errors in previous versions of the genome reference assembly for GRC-supported assemblies. The FTP sites for both databases provide XML, tabdelimited and GFF-format files. Ultimately, through these efforts, the structural variation archives promise to greatly assist all studies of genetic variation. have been submitted this way, such as nstd19 (Quinlan et al.) 11 , nstd31 (Alkan et al.) 12 and nstd35 (Kidd et al.) 13 . Submission instructions and example submissions for dbVar can be found on the dbVar website. Submission information for DGVa is available through the EBI submission page. Most of the studies currently available do not have base-level precision, and the technologies for identifying structural variation are rapidly changing. In fact, few variants are defined at the breakpoint level, and both dbVar and DGVa encourage submitters to provide the breakpoint range and level of resolution for each analysis. Both archives are attempting to develop more robust ways to graphically represent lack of precision. We collect all supporting information for variant assertions, including descriptions of methods, analysis and the raw data used in the study (through Array Express GEO or the Sequence Read Archive/European Read Archive). Additionally, variant regions are only considered validated if a separate experimental analysis has been performed and the resulting data is also collected and presented to users. We can accept populationbased data, such as genotype or copy number analysis, although this is not required. We will accept data for all studies that have been submitted to a peer review journal, and we will also accept unpublished data from large-scale community-based projects before publication to facilitate community access. We are working directly with several large-scale projects such as the Human Structural Variation Database, the 1000 Genomes Project and the International Standards for Cytogenomic Arrays Consortium 14 to ensure their data are updated in the database regularly.
Although dbVar and DGVa plan to store the same data, they have different and complementary plans for providing data Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis
In a recent publication in Nature Genetics 1 , Mahdi et al. investigated gene-environment interactions and the specific association with autoantibodies to citrullinated α-enolase in order to get an impression of the etiologic importance of this antigen in susceptibility to rheumatoid arthritis. Mahdi et al. 1 report that a specific interaction is present between genotype, smoking and autoimmunity to a citrullinated α-enolase peptide (CEP-1), suggesting that the major genetic and environmental susceptibility factors for rheumatoid arthritis are associated mainly with the development of anti-CEP1-positive disease.
As referenced by Mahdi et al. 1 , important pathophysiological insight has been obtained in the past decade by the identification of anti-citrullinated protein antibodies (ACPA). ACPA are highly specific for rheumatoid arthritis and have been implicated in disease etiology 2, 3 . It has now become clear that rheumatoid
